| Target Audience: Physicians of all specialties who may be prescribing anticoagulant therapy for their patients with nonvalvular atrial fibrillation. Other interested healthcare providers are also welcome to participate.
Original Release Date: July 16, 2012
Review Date:
Expiration Date: July 16, 2014
Description: Managing anticoagulant therapy has always been a delicate balancing act between thrombus and hemorrhage. Between 2010 and 2012, new options (direct thrombin inhibitor and new direct Factor Xa inhibitors) became available. This Internet activity seeks to provide risk management suggestions for physicians who are considering their options for anticoagulation therapy for their patients with nonvalvular atrial fibrillation. Data from phase III clinical trials and recommendations from medical specialty organizations will be reviewed to identify considerations in prescribing new and old anticoagulants to patients.
Learning Objectives: Upon successful completion, participants should be able to:
1. Describe the benefits and risks of dabigatran and rivaroxaban.
2. Define noninferiority trials and explain their limitations.
3. State existing professional recommendations about what to do with patients who are stable on warfarin and why.
4. Identify strategies to minimize risks associated with implementing a new anticoagulant therapy option in clinical practice.
Learning Assessment: There will be a post test for this activity with a minimum performance requirement of 4 out of 5 correct answers.
Estimated time to complete activity:1 hour
Method and Medium: To obtain CME credit, view the entire online presentation, complete the evaluation and post test and print your certificate online.
CME Credit: 1.0
State Requirements:
Based on information from state licensing authorities published by the AMA, this program meets specific CME requirements for the following states:
Florida - This activity includes content in Preventing Medical Errors
Connecticut - This activity includes content in Risk Management
Massachusetts - This activity includes content in Risk Management
Pennsylvania - This activity includes content in Risk Management / Patient Safety
CME Information - Read
Disclosure Policy - Read
Disclosure: The speaker, editors and planning committee members for this activity have no relevant financial relationships to disclose.
About the Speakers - Read full bios
Narrator: Karl N. Hanson, MD, FAAFP
Expert Reviewers: F. Jeff White III, MD, FAACP and Karl N. Hanson, MD, FAAFP
Medical writers: Sara N. Fischer, PhD, & Ruth Ryan
Managing Editor: Dawer Azizi, MHA, CPHRM, LAMMICO Manager of Risk Management
Editor: Ruth Ryan RN, BSN, MSW, CPHRM, LAMMICO Risk Management Education Specialist
Content Advisors/Planning Committee Members - Read
Electronic Hardware and Software Requirements - Read
Web Master Contact Information: For assistance, contact Shea Ivey at 855/464-7475 or help@medicalinteractive.com
Disclaimer: This activity is presented as risk management education. It is not legal advice, nor does it establish medical standards of care. Standards of care vary depending on the unique presentation of each patient. The information contained herein is not a substitute for the reasonable discretion of skilled and informed clinicians at the point of care.
Copyright Information: Copyright © 2012
Bibliography: To view and download a Bibliography for this presentation, please select the References button below.
 |
